Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder

Current Opinion in Psychiatry

Volumn 22, Issue 3, 2009, Pages 312-319

  Fornito, Alex ^a,b   Yücel, Murat ^a,c   Pantelis, Christos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

Cortex; Depression; Glia; Neuron; Psychosis

Indexed keywords

BIPOLAR DISORDER; BRAIN MALFORMATION; BRAIN REGION; BRAIN SIZE; DISEASE COURSE; HUMAN; NERVE CELL NETWORK; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

BIPOLAR DISORDER; BRAIN; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; FRONTAL LOBE; GYRUS CINGULI; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; TEMPORAL LOBE; THALAMUS;

EID: 67651085447     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32832a1353     Document Type: Review

References (108)

1. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry 2002; 59:533-558.
2. Mathalon DH, Rapoport JL, Davis KL, Krystal JH. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. Arch Gen Psychiatry 2003; 60:846-848; author reply 848-849.
3. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000; 11 (6 Pt 1):805-821.
4. Mechelli A, Price CJ, Friston KJ, Ashburner J. Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 2005; 1:105-113.
5. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162:2233-2245. (Pubitemid 41740200)
6. Ellison-Wright I, Glahn DC, Laird AR, et al. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008; 165:1015-1023. The first application of the anatomical likelihood estimation (ALE) technique to meta-analyse VBM studies in chronic and first episode schizophrenia patients. The ALE approach allowed the authors to construct voxel-wise maps of regions most consistently reported as showing significant differences in the literature.
7. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008; 64:774-781. Applies the ALE technique to meta-analyse VBM studies in schizophrenia and conducts an additional analysis to examine the pattern of interregional covariation of significant grey matter differences reported in the literature.
8. Borgwardt SJ, McGuire PK, Aston J, et al. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry Suppl 2007; 51:s69-s75. One of a pair of papers by this group examining brain changes in HRS individuals before the onset of psychosis. This article presents comparisons between high-risk individuals who make the transition to psychosis, healthy controls, and first episode patients. (Pubitemid 350273192)
9. Borgwardt SJ, Riecher-Rossler A, Dazzan P, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 2007; 61: 1148-1156. One of a pair of papers by this group examining brain changes in HRS individuals before the onset of psychosis. This article presents comparisons between high-risk individuals who do and do not transition to psychosis, in addition to a comparison between the high-risk group (as a whole), first episode patients, and controls. (Pubitemid 46669460)
10. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361:281-288. (Pubitemid 36126187)
11. Sun D, Stuart GW, Jenkinson M, et al. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 2008 [Epub ahead of print]. doi:10.1038/mp.2008.34. Combines measures of grey matter density and surface retraction to map longitudinal changes occurring in the first 2-3 years following a first episode of schizophrenia.
12. Van Essen DC. A Population-Average, Landmark- and Surface-based (PALS) atlas of human cerebral cortex. Neuroimage 2005; 28:635-662.
13. Fornito A, Yucel M, Patti J, et al. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 2009; 108:104-113.
14. Grace AA. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 2000; 31:330-341. (Pubitemid 30136188)
15. Fornito A, Whittle S, Wood SJ, et al. The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex. Neuroimage 2006; 33:843-854. (Pubitemid 44739997)
16. Bookstein FL. 'Voxel-based morphometry' should not be used with imperfectly registered images. Neuroimage 2001; 14:1454-1462.
17. Crum WR, Griffin LD, Hill DLG, Hawkes DJ. Zen and the art of medical image registration: correspondence, homology, and quantity. Neuroimage 2003; 20:1425-1437.
18. Pantelis C, Yucel M, Wood SJ, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 2005; 31:672-696. (Pubitemid 41253318)
19. Wood SJ, Pantelis C, Velakoulis D, et al. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull 2008; 34:322-329. Part of a series of articles published in the same issue examining neurobiological changes across the course of schizophrenia. This article reviews changes observed in sMRI studies in HRS individuals before, during, and after the transition to frank psychosis. (Pubitemid 351323332)
20. Lawrie SM, McIntosh AM, Hall J, et al. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull 2008; 34:330-340. Part of a series of articles published in the same issue examining neurobiological changes across the course of schizophrenia. This article reviews work conducted on individuals at genetic high-risk for schizophrenia. (Pubitemid 351323338)
21. Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 2008; 34:354-366. Part of a series of articles published in the same issue examining neurobiological changes across the course of schizophrenia. This article focuses on longitudinal changes occurring after the first episode in patients with established and chronic illness.
22. Yung AR, Phllips LJ, McGorry PD. Treating schizophrenia in the prodromal phase. London: Taylor & Francis; 2004.
23. Garner B, Pariante CM, Wood SJ, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 2005; 58:417-423. (Pubitemid 41219710)
24. Fornito A, Yung AR, Wood SJ, et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry 2008; 64:758-765. One of the few studies to examine the diagnostic specificity of prepsychotic brain changes in high-risk individuals, finding that preonset grey matter reductions in the ACC are relatively specific to individuals who subsequently develop a schizophrenia- spectrum disorder.
25. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005; 25:1023-1030.
26. Job DE, Whalley HC, McConnell S, et al. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res 2003; 64:1-13. (Pubitemid 37153344)
27. Harris JM, Moorhead TW, Miller P, et al. Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia reflects abnormal prefrontal development. Biol Psychiatry 2007; 62:722-729. (Pubitemid 47374645)
28. Harris JM, Whalley H, Yates S, et al. Abnormal cortical folding in high-risk individuals: a predictor of the development of schizoprhenia? Biol Psychiatry 2004; 56:182-189.
29. Borgwardt SJ, McGuire PK, Aston J, et al. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res 2008; 106:108-114.
30. Sowell ER, Thompson PM, Tessner KD, Toga AW. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci 2001; 21:8819-8829.
31. Shaw P, Greenstein D, Lerch J, et al. Intellectual ability and cortical development in children and adolescents. Nature 2006; 440:676-679.
32. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 2004; 101:8174-8179. (Pubitemid 38698073)
33. Sun D, Phillips LJ, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res 2008; 108:85-92.
34. Takahashi T, Wood SJ, Yung AR, et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. ArchGen Psychiatry (in press).
35. Farrow TF, Whitford TJ, Williams LM, et al. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 2005; 58:713-723.
36. Whitford TJ, Grieve SM, Farrow TF, et al. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensorbased morphometry study. Neuroimage 2006; 32:511-519.
37. Koo MS, Levitt JJ, Salisbury DF, et al. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 2008; 65:746-760. Detailed ROI study comparing longitudinal changes in the ACC occurring after a first episode of schizophrenia or bipolar disorder.
38. Harrison PJ. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 1999; 122:593-624.
39. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999; 45:17-25.
40. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol 1998; 392:402-412. (Pubitemid 28165894)
41. Selemon LD, Mrzljak J, Kleinman JE, et al. Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. Arch Gen Psychiatry 2003; 60:69-77. (Pubitemid 36070867)
42. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001; 50:395-406. (Pubitemid 32885589)
43. BenesFM, Majocha R, Bird ED,Marotta CA. Increased vertical axonnumbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry 1987; 44:1017-1021.
44. Benes FM, Sorensen I, Vincent SL, et al. Increased density of glutamateimmunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 1992; 2:503-512.
45. Todtenkopf MS, Vincent SL, Benes FM. A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res 2005; 73:79-89.
46. Fornito A, Yucel M, Dean B, et al. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull 2008. doi:10.1093/schbul/sbn025. A systematic review of neuroimaging and neuropathological findings of the ACC in schizophrenia, with a consideration of their implications for pathophysiological models.
47. Glantz LA, Lewis DA. Dendritic spine density in schizophrenia and depression. Arch Gen Psychiatry 2001; 58:203.
48. Cotter D, Mackay D, Landau S, et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58:545-553. (Pubitemid 32523734)
49. Kreczmanski P, Schmidt-Kastner R, Heinsen H, et al. Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathol 2005; 109:510-518. (Pubitemid 40909196)
50. Bouras C, Kovari E, Hof PR, et al. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berl) 2001; 102: 373-379. (Pubitemid 32894708)
51. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004; 61:649-657.
52. Zhang Z, Sun J, Reynolds GP. A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients. Chin Med J (Engl) 2002; 115:819-823. (Pubitemid 34716389)
53. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998; 44:88-97.
54. Chance SA, Walker M, Crow TJ. Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia. Brain Res 2005; 1046 (1-2):32-37. (Pubitemid 40775871)
55. Braitenberg V. Brain size and number of neurons: an exercise in synthetic neuroanatomy. J Comput Neurosci 2001; 10:71-77. (Pubitemid 32243554)
56. Braitenberg V, Schüz A. Cortex: statistics and geometry of neuronal connectivity. 2nd ed. Berlin: Springer-Verlag; 2001.
57. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 2005; 9:60-68. (Pubitemid 40164471)
58. Young KA, Manaye KF, Liang C, et al. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 2000; 47:944-953. (Pubitemid 30320739)
59. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028. (Pubitemid 20377512)
60. Kreczmanski P, Heinsen H, Mantua V, et al. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 2007; 130 (Pt 3):678-692.
61. Danos P, Schmidt A, Baumann B, et al. Volume and neuron number of the mediodorsal thalamic nucleus in schizophrenia: a replication study. Psychiatry Res 2005; 140:281-289.
62. Cullen TJ, Walker MA, Parkinson N, et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr Res 2003; 60:157-166. (Pubitemid 36184706)
63. Chana G, Landau S, Beasley C, et al. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003; 53: 1086-1098. (Pubitemid 36695084)
64. Cotter D, Landau S, Beasley C, et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002; 51:377-386. (Pubitemid 34251175)
65. Heckers S, Heinsen H, Geiger B, Beckmann H. Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry 1991; 48:1002-1008.
66. Benes FM, Lange N. Two-dimensional versus three-dimensional cell counting: a practical perspective. Trends Neurosci 2001; 24:11-17. (Pubitemid 32332892)
67. Danos P, Baumann B, Bernstein HG, et al. The ventral lateral posterior nucleus of the thalamus in schizophrenia: a postmortem study. Psychiatry Res 2002; 114:1-9. (Pubitemid 34178342)
68. Selemon LD. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr Bull 2001; 27:349-377.
69. Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65:1017-1032. A comprehensive and thorough meta-analysis of sMRI studies of bipolar disorder.
70. McDonald C, Zanelli J, Rabe-Hesketh S, et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 2004; 56:411-417. (Pubitemid 39195321)
71. Hajek T, Kozeny J, KopecekM, et al. Reduced subgenual cingulate volumes in mood disorders: a meta-analysis. J Psychiatry Neurosci 2008; 33:91-99. Meta-analysis of sMRI studies of the subgenual cingulate region in bipolar disorder and depression, a brain region frequently implicated in the pathophysiology of both illnesses.
72. Videbech P, Ravnkilde B. Hippocampal volume and depression: a metaanalysis of MRI studies. Am J Psychiatry 2004; 161:1957-1966. (Pubitemid 39441394)
73. Lyoo IK, Kim MJ, Stoll AL, et al. Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry 2004; 55:648-651. (Pubitemid 38315040)
74. Lyoo IK, Sung YH, Dager SR, et al. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 2006; 8:65-74.
75. Nugent AC, Milham MP, Bain EE, et al. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 2006; 30:485-497.
76. Lochhead RA, Parsey RV, Oquendo MA, Mann JJ. Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry. Biol Psychiatry 2004; 55:1154-1162.
77. Doris A, Belton E, Ebmeier KP, et al. Reduction of cingulate gray matter density in poor outcome bipolar illness. Psychiatry Res 2004; 130:153-159. (Pubitemid 38366436)
78. Adler CM, Levine AD, DelBello MP, Strakowski SM. Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 2005; 58:151-157. (Pubitemid 41008132)
79. Bearden CE, Thompson PM, Dalwani M, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 2007; 62:7-16. Uses a sophisticated variant of VBM to map grey matter changes in bipolar patients, showing that many of the grey matter increases observed in their patient group may be due to treatment with lithium. (Pubitemid 46898230)
80. Adler CM, DelBello MP, Jarvis K, et al. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 2007; 61:776-781. (Pubitemid 46330240)
81. Fornito A, Yücel M, Wood SJ, et al. Anterior cingulate cortex abnormalities associated with a first psychotic episode in bipolar disorder. Br J Psychiatry 2009. doi: 10.1192/bjp/bp/107/049205.
82. Kubicki M, Shenton ME, Salisbury DF, et al. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 2002; 17:1711-1719. (Pubitemid 36062762)
83. Janssen J, Reig S, Parellada M, et al. Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry 2008; 47:1311-1320. One of the few VBM studies of first episode bipolar psychosis.
84. Hirayasu Y, Shenton ME, Salisbury DF, et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999; 156:1091-1093. (Pubitemid 29302806)
85. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827.
86. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998; 95:13290-13295. (Pubitemid 28509564)
87. Gogtay N, Ordonez A, Herman DH, et al. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J Child Psychol Psychiatry 2007; 48:852-862. The only study, to our knowledge, to have examined brain changes occurring before and after the onset of a bipolar illness. (Pubitemid 47244898)
88. Moorhead TW, McKirdy J, Sussmann JE, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007; 62:894-900. One of the few longitudinal MRI studies of bipolar disorder. (Pubitemid 47488221)
89. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001; 49:741-752. (Pubitemid 32452295)
90. Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 2001; 55:569-578.
91. Harrison PJ. The neuropathology of primary mood disorder. Brain 2002; 125 (Pt 7):1428-1449.
92. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25:1-27. (Pubitemid 32493819)
93. Pantazopoulos H, Lange N, Baldessarini RJ, Berretta S. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry 2007; 61:640-652. Notable for identifying reductions in specific subtypes of GABAergic neurons in the entorhinal cortex of bipolar patients. (Pubitemid 46328851)
94. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord 2002; 4:105-116.
95. Haldane M, Frangou S. New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:943-960. (Pubitemid 39223350)
96. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55:215-224. (Pubitemid 28128608)
97. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000; 57:637-648.
98. Karlsgodt KH, Sun D, Jimenez AM, et al. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 2008; 20:1297-1327.
99. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:846-858.
100. Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 2006; 11:241-251. (Pubitemid 43316055)
101. Benes FM, Walsh J, Bhattacharyya S, et al. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch Gen Psychiatry 2003; 60:359-364. (Pubitemid 36402995)
102. Buttner N, Bhattacharyya S, Walsh J, Benes FM. DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res 2007; 93:33-41. (Pubitemid 46817926)
103. Benes FM. Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophr Bull 2007; 33:932-936. Concise review of recent post-mortem work by this group examining markers of apoptotic activity in schizophrenia and bipolar disorder, highlighting intriguing findings suggesting there may be a fundamental difference in the way apoptotic pathways are affected by these two illnesses.
104. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6:312-324.
105. Woo TU, Kim AM, Viscidi E. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res 2008; 1218:267-277.
106. Woo TU, Shrestha K, Lamb D, et al. N-methyl-D-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Biol Psychiatry 2008; 64:803-809. One of the few studies to examine combined pathology of the GABA and glutamate systems in schizophrenia and bipolar disorder.
107. Bora E, Yucel M, Fornito A, et al. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers? Acta Psychiatr Scand 2008; 118:172-187. Reviews neurobiological and neuropsychological findings in studies of patients with so-called 'intermediate syndromes' - patients showing a mixture of prototypical schizophrenic and bipolar symptoms - to elucidate phenotypic continuities between the two.
108. Jissendi Tchofo P, Baleriaux D. Brain (1)H-MR spectroscopy in clinical neuroimaging at 3T. J Neuroradiol 2008 [Epub ahead of print].